Home › Blog › Weight Loss › Weight Loss Injections Edinburgh
Weight Loss Injections Edinburgh 2026: NHS Lothian Routes, Free Prescriptions, and Private From £139
Get Weight Loss Injections in Edinburgh — Delivered Tomorrow, No Waiting List
Same MHRA-licensed Mounjaro and Wegovy as NHS Lothian · GPhC No. 1033729 · NHS-contracted · SCOPE Obesity Accredited · LegitScript Certified · Free monthly check-ins included
Wegovy from £99.99/month
✓ Free monthly check-ins
✓ Free starter pack
✓ No subscription
✓ Next-day to all EH postcodes
Edinburgh is Scotland’s capital city and the country’s financial and cultural heart. With a population of approximately 550,000 in Edinburgh City alone — and over 900,000 across the wider NHS Lothian area including East Lothian, Midlothian, and West Lothian — the demand for weight loss injections is significant and growing rapidly.
For Edinburgh patients, 2026 brings two pieces of news that are uniquely important. The first is familiar to anyone who has looked into this: NHS Lothian tier 3 weight management waiting times are 12–24 months. The second is the fact that most guides don’t lead with: NHS prescriptions in Scotland are completely free. No prescription charge applies to any medication in Scotland — including Mounjaro and Wegovy. If you can access NHS Mounjaro or Wegovy through NHS Lothian, you will pay nothing for it. The challenge is getting there — and this guide explains every route.
How to Get Weight Loss Injections in Edinburgh: NHS vs Private
| Factor | NHS — via NHS Lothian | Private — Slinic |
|---|---|---|
| Eligibility threshold | BMI 35+ with qualifying conditions (tier 3) · BMI 27+ with CVD no T2D (cardiovascular pathway) · T2D patients (T2D Mounjaro pathway) | BMI 30+ (no condition) · BMI 27+ with 1 qualifying condition · Ethnic group adjustments apply |
| GP referral needed | Yes — GP referral to NHS Lothian tier 3 service or April 2026 GP direct pathways | No — free online assessment directly with Slinic |
| Waiting time | 12–24 months from GP referral | 24–48 hours from assessment approval to delivery |
| Cost | Free — no NHS prescription charge in Scotland | £139–£285/month (Mounjaro) · £99.99–£209.99 (Wegovy) · £4.99 delivery |
| Monthly monitoring | NHS Lothian tier 3 multidisciplinary team | Free monthly check-ins with Slinic superintendent pharmacist — always included in price |
| Free starter pack | Via NHS Lothian tier 3 service | ✓ Needles + sharps bin with first order |
| Can run simultaneously? | ✓ Yes — being on the NHS Lothian waiting list and starting Slinic privately are fully compatible. Starting private treatment does not affect your NHS Lothian position. Many Edinburgh patients use both routes simultaneously — the bridge strategy. | |
Scotland vs England: Why the NHS Picture Is Different for Edinburgh
| Factor | England | Scotland / Edinburgh |
|---|---|---|
| Clinical approval body | NICE (National Institute for Health and Care Excellence) | SMC (Scottish Medicines Consortium) |
| Mounjaro approval | NICE TA1026 — June 2025 | SMC approved separately — broadly similar obesity management criteria |
| Wegovy approval | NICE TA875 — March 2023 + CV label April 2026 | SMC approved — ask your Edinburgh GP about the current cardiovascular prescribing pathway in Scotland |
| NHS prescription charge | £9.90 per item in England | Free — no prescription charge in Scotland |
| T2D Mounjaro pathway | QOF incorporated April 2026 in England | Separate Scottish GMS contract framework — ask your Edinburgh GP for current position |
| Tier 3 waiting times | 12–36 months depending on ICB and locality | NHS Lothian: approximately 12–24 months |
| Private prescribing | Available UK-wide | Fully legal — GPhC-registered English pharmacies can prescribe to Scottish patients. Slinic delivers to all EH postcodes next day. |
Obesity Across Edinburgh and the Lothians: Area-by-Area Breakdown
Edinburgh City’s overall 28% adult obesity rate — below the Scottish national average of 31% — conceals significant local variation driven by deprivation and geography. Understanding which area you live in matters both for your NHS referral priority and for contextualising your clinical need.
| Area | Adult obesity rate | Key characteristics for weight loss injection access | EH postcodes |
|---|---|---|---|
| Wester Hailes, Sighthill, Dumbiedykes | 35–40% | Among Edinburgh’s most deprived wards. Very high CVD and T2D rates. NHS Lothian public health priority areas. April 2026 cardiovascular Wegovy pathway highly relevant for eligible patients here. | EH11, EH14 |
| Muirhouse, Pilton, Granton, Drylaw | 34–38% | High deprivation. Above-average T2D, hypertension, and sleep apnoea rates. High demand for tier 3 services — contributing to NHS Lothian wait times. | EH4, EH5 |
| Craigmillar, Niddrie, Greendykes, Moredun | 33–37% | High deprivation. NHS Lothian public health priority areas. High CVD and T2D burden. Significant unmet need for weight management services. | EH16, EH17 |
| Leith, Pilrig, Easter Road, Restalrig | 28–33% | Mixed demographics. South Asian, Black African, and Eastern European communities in parts of Leith — ethnic BMI adjustments relevant. Above-average T2D in South Asian community. | EH6, EH7 |
| Gorgie, Dalry, Stenhouse | 26–31% | Mixed working-class community. Average to above-average obesity. Above-average hypertension rates. | EH11, EH14 |
| Portobello, Musselburgh | 25–29% | Coastal suburban. Mixed demographics. Average rates. Musselburgh is East Lothian — NHS Lothian covers both. | EH15, EH21 |
| Central Edinburgh (New Town, Stockbridge, Marchmont) | 18–24% | More affluent. Below-average obesity. High Slinic private prescribing uptake — many patients choosing private route for speed and clinical quality. | EH1–EH4, EH9, EH10 |
| South Edinburgh (Morningside, Colinton, Fairmilehead, Liberton) | 20–26% | Among Edinburgh’s most affluent areas. Significantly below-average rates. High private prescribing uptake. | EH10, EH13, EH16 |
| East Lothian (Haddington, North Berwick, Dunbar) | 26–31% | Average to above-average rates. Rural areas — Slinic’s online model removes the rural access barrier. No travel needed for assessment or monthly check-ins. | EH31–EH42 |
| Midlothian (Dalkeith, Bonnyrigg, Penicuik, Loanhead) | 28–33% | Above-average rates. Tier 3 services typically via Edinburgh city. Slinic next-day delivery to all Midlothian EH postcodes. | EH18–EH27 |
| West Lothian (Livingston, Bathgate, Linlithgow, Armadale) | 30–35% | Above-average obesity and CVD burden. Livingston has significant deprivation pockets alongside more affluent areas. St John’s Hospital is local A&E reference. EH47–EH55 postcodes covered by Slinic next-day delivery. | EH47–EH55 |
Ethnic Group BMI Adjustments — What Edinburgh Patients From South Asian, Black, and East Asian Backgrounds Need to Know
Edinburgh has a smaller ethnic minority population than Glasgow or most English cities, but significant Pakistani, Indian, Chinese, and Black African/Caribbean communities concentrated in Leith, Southside, and parts of the city centre. For patients from these backgrounds, the ethnic group BMI adjustments at Slinic are clinically critical and applied automatically.
The clinical basis: patients from South Asian, Black African/Caribbean, Chinese, and Middle Eastern backgrounds develop type 2 diabetes, cardiovascular disease, and metabolic syndrome at significantly lower BMIs than white European patients. A South Asian patient with BMI 25 faces equivalent or greater metabolic risk as a white European patient with BMI 30 — equivalent visceral adiposity, equivalent insulin resistance, equivalent cardiovascular risk markers. This is established in peer-reviewed literature including WHO expert consultation guidance and Diabetes UK’s South Asian diabetes risk framework.
| Ethnic background | Standard Slinic threshold | Adjusted Slinic threshold | Edinburgh communities most affected |
|---|---|---|---|
| South Asian (Pakistani, Bangladeshi, Indian, Sri Lankan) | BMI 30+ (no condition) · BMI 27+ (with condition) | BMI 27.5+ (no condition) · BMI 23+ (with condition) | Leith, Southside, parts of Newington and Gorgie |
| Black African / Black Caribbean | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | Leith, parts of central Edinburgh |
| Chinese / East Asian | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | City centre, Southside, Newington (student population) |
| Middle Eastern / North African | BMI 30+ · BMI 27+ | BMI 27.5+ · BMI 23+ | Central Edinburgh, parts of Leith |
NHS Weight Loss Injections in Edinburgh: The Three Routes in 2026
NHS Lothian Tier 3 Weight Management
⏰ Wait: 12–24 months from GP referral
The primary NHS route for Edinburgh patients. Your GP refers you to NHS Lothian’s tier 3 specialist weight management service. Eligibility criteria broadly follow SMC guidance: BMI 35 or above with at least one qualifying condition. Medication is completely free — no prescription charge in Scotland.
- BMI 35+ with at least one qualifying condition (T2D, hypertension, CVD, high cholesterol, sleep apnoea, NAFLD, PCOS, obesity-related osteoarthritis)
- GP referral to NHS Lothian tier 3 weight management service required
- Typically evidence of engagement with other weight management approaches
- Multidisciplinary assessment before medication is prescribed
- Medication: free in Scotland — no prescription charge. Mounjaro or Wegovy depending on clinical recommendation.
Ask your Edinburgh GP for a tier 3 referral today — every day without a referral is a day added to a wait that is already 12–24 months.
Cardiovascular Pathway — Wegovy for CVD Patients (Scottish Equivalent)
⚡ Potentially faster than tier 3 — ask your Edinburgh GP
England introduced a direct GP cardiovascular Wegovy prescribing pathway in April 2026, following the SELECT trial (NEJM 2023) showing a 20% reduction in major cardiovascular events. Scotland has an equivalent pathway through SMC and the Scottish GMS contract — timing and criteria may differ from England’s NICE version.
- BMI 27 or above
- Established cardiovascular disease: prior myocardial infarction, prior stroke or TIA, or peripheral arterial disease
- No type 2 diabetes
If you have had a heart attack, stroke, or TIA and your BMI is 27 or above: ask your Edinburgh GP specifically about the Scottish cardiovascular semaglutide prescribing pathway. It may be significantly faster than tier 3.
Type 2 Diabetes Pathway — Mounjaro for T2D Patients (Scottish Equivalent)
⚡ Potentially faster than tier 3 — ask your Edinburgh GP
England incorporated Mounjaro into the NHS QOF for type 2 diabetes in April 2026. Scotland has a separate pathway through the Scottish GMS contract for T2D prescribing. Mounjaro is the only weight loss medication in the UK with a dual licence for both weight management AND type 2 diabetes control — making it uniquely valuable for T2D patients.
- Type 2 diabetes — the primary qualifying criterion
- Ask your Edinburgh GP about the current Scottish T2D Mounjaro prescribing pathway
- If prescribed through NHS Scotland: completely free — no prescription charge
- SURPASS-2 clinical data: 15mg Mounjaro reduced HbA1c by 2.58% on average (NEJM 2021) — strongest of any approved T2D treatment
If you have type 2 diabetes: ask your Edinburgh GP whether Mounjaro is available through your T2D management framework.
Step 1 (Today): Ask your Edinburgh GP for an NHS Lothian tier 3 referral. Also ask about the Scottish cardiovascular Wegovy pathway (if BMI 27+ with established CVD, no T2D) and the Scottish T2D Mounjaro pathway (if T2D). Start the NHS clock now.
Step 2 (Today): Complete Slinic’s free 2-minute eligibility assessment. If eligible, medication is at your Edinburgh address tomorrow.
Step 3 (Now until NHS appointment): Continue private Slinic treatment. Begin losing weight now — not in 12–24 months. Free monthly check-ins track progress, manage dose escalation, and build your clinical record.
Step 4 (When NHS appointment arrives): Transition to completely free NHS Lothian supply at your current established dose. Your Slinic records provide the NHS team with a complete treatment history. No restart from the beginning. Free Mounjaro or Wegovy indefinitely.
Starting private treatment at Slinic does not affect your NHS Lothian waiting list position.
Can’t Wait for NHS Lothian? Slinic Has No Waiting List
Mounjaro from £139 · Wegovy from £99.99 · Next-day to all EH postcodes · Free monthly check-ins · GPhC No. 1033729 · NHS-contracted · LegitScript certified
Mounjaro for Edinburgh T2D Patients — What Makes It Unique
Edinburgh and the Lothians have approximately 7.8% T2D prevalence among adults — higher in deprived communities including Wester Hailes, Muirhouse, and Craigmillar. For Edinburgh T2D patients, Mounjaro offers something no other weight loss medication can match:
- Dual licence — the only UK weight loss medication licensed for both weight management AND type 2 diabetes control simultaneously. One medication for two major conditions.
- Exceptional glycaemic control — SURPASS-2 (NEJM 2021): 15mg Mounjaro reduced HbA1c by 2.58 percentage points on average — the strongest of any approved T2D treatment in published clinical trials
- Simultaneous weight loss — 22.5% average weight loss at 15mg alongside glycaemic control (SURMOUNT-1, NEJM 2022)
- Medication coordination required — as blood sugar improves, insulin and sulphonylurea doses must be reduced under clinical supervision. Your monthly Slinic check-in includes clinical guidance and flags concerns requiring Edinburgh GP input
- If prescribed through NHS Scotland: completely free
Private Weight Loss Injections Edinburgh — Slinic’s Fixed 2026 Prices
MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain and Wegovy from Novo Nordisk’s authorised UK supply chain. Fixed 2026 prices. No subscription. Next-day delivery to all Edinburgh EH postcodes.
| Medication & dose | Slinic price | Delivery | Monthly total | Treatment stage & clinical data |
|---|---|---|---|---|
| Mounjaro 2.5mg | £139.00 | £4.99 | £143.99 | Starting dose (weeks 1–4). Body adaptation. Appetite begins to reduce significantly within 1–2 weeks. Free starter pack (needles + sharps bin) with first order. |
| Mounjaro 5mg | £165.00 | £4.99 | £169.99 | First therapeutic dose (weeks 5–8). Appetite suppression significantly stronger. Weight loss accelerating. |
| Mounjaro 7.5mg | £225.00 | £4.99 | £229.99 | Mid-escalation (weeks 9–12). Average ~8–9% cumulative weight loss in SURMOUNT-1 data. |
| Mounjaro 10mg | £255.00 | £4.99 | £259.99 | Upper escalation. 19.5% average weight loss at this dose in trials. Many Edinburgh patients maintain here. |
| Mounjaro 12.5mg | £275.00 | £4.99 | £279.99 | High maintenance. Near-maximum efficacy. ~18–20% cumulative average. |
| Mounjaro 15mg | £285.00 | £4.99 | £289.99 | Maximum dose. 22.5% average weight loss at 72 weeks (SURMOUNT-1 · NEJM 2022). 57% of 15mg patients achieved 20%+ weight loss. |
| Wegovy 0.25mg | £99.99 | £4.99 | £104.98 | Starting dose. Body adaptation. Free starter pack included with first order. |
| Wegovy 0.5mg | £109.99 | £4.99 | £114.98 | Month 2. Appetite suppression establishing. |
| Wegovy 1mg | £114.99 | £4.99 | £119.98 | Month 3. Entering therapeutic range. |
| Wegovy 1.7mg | £159.99 | £4.99 | £164.98 | Month 4. ~10–12% cumulative average. |
| Wegovy 2.4mg | £209.99 | £4.99 | £214.98 | Maintenance dose. 14.9% average (STEP 1, NEJM 2021). NICE CV approval April 2026. |
Each pen contains 4 weekly doses. Fixed 2026 prices — no subscription, no minimum term, no cancellation fee. Compare: MedExpress £179.99 starting · Boots £176.97 starting · Voy £167+ with subscription required.
Am I Eligible for Weight Loss Injections in Edinburgh?
- ✓ BMI 30 or above — no qualifying condition needed at Slinic. BMI alone qualifies you.
- ✓ BMI 27–29.9 with at least one qualifying condition: T2D, hypertension, cardiovascular disease, high cholesterol, sleep apnoea, NAFLD, PCOS, or obesity-related osteoarthritis
- ✓ South Asian / Black African/Caribbean / Chinese / Middle Eastern background — BMI 27.5+ without condition, or BMI 23+ with condition — applied automatically at assessment
- ✓ Age 18 or over
- ✗ Contraindications that prevent prescribing — personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2) · pregnant or breastfeeding · under 18 · active pancreatitis · currently on another GLP-1 agonist
Expected Results on Mounjaro — Edinburgh Patients
Based on SURMOUNT-1 trial data (NEJM 2022) — 2,539 patients, 72 weeks. For a patient starting at 100kg:
| Timepoint | Dose | Average % loss | Real weight (100kg patient) | What Edinburgh patients typically experience |
|---|---|---|---|---|
| Month 1 | 2.5mg | ~3–4% | ~3–4 kg | Appetite noticeably quieter within 1–2 weeks. The constant background thinking about food significantly reduced. Scale beginning to move. |
| Month 3 | 7.5mg | ~8–9% | ~8–9 kg | Clothes fitting differently. Energy increasing. Others beginning to notice. Motivation typically peaks as visible results emerge. |
| Month 6 | 10–12.5mg | ~14–15% | ~14–15 kg | Major physical transformation. Blood pressure, blood sugar, and lipids all typically improved. Many patients review other medications with their GP at this stage. |
| Month 12 | 15mg | ~20–21% | ~20–21 kg | Profound health transformation. Quality of life, mood, energy, mobility, and sleep all typically improved alongside metabolic markers. |
| Month 18 | 15mg | 22.5% | ~22.5 kg | Full SURMOUNT-1 trial result. 57% of 15mg patients achieved 20%+ total weight loss — comparable to bariatric surgery outcomes without surgical risk. |
What Slinic Includes for Edinburgh Patients
| What’s included | Details |
|---|---|
| Full clinical assessment | Every prescription reviewed by Shadeia Younis or her registered clinical team. Contraindication screening, drug interaction review, ethnic threshold assessment. Never automated — always reviewed by a real prescriber. |
| Free starter pack | Needles and sharps bin included with every first order. Everything you need to begin on day one. |
| Free monthly clinical check-ins | Structured review: weight progress, dose escalation management, side effect support, nutritional guidance. Always included in the medication price — never charged separately. |
| Cold-chain next-day delivery to Edinburgh | All Edinburgh and Lothians postcodes: EH1–EH55 covering Edinburgh City, East Lothian, Midlothian, and West Lothian. Certified cold-chain maintaining 2–8°C throughout transit. |
| No subscription or minimum term | Order when ready. No automatic billing. No cancellation fee. No lock-in. Complete flexibility. |
| NHS contract | The same governance and audit standard as NHS pharmacies — the highest standard in UK pharmacy. No private weight loss competitor holds this. |
| SCOPE Obesity accreditation | Specialist obesity clinical competency — Slinic is specifically assessed for obesity care, beyond general prescribing authority. scopeforpractitioners.com |
| LegitScript certification | International online pharmacy verification used by Google and international regulators. legitscript.com |
Side Effects: What Edinburgh Patients Should Know
| Side effect | Rate at Mounjaro 15mg | Timing | What to do at Slinic |
|---|---|---|---|
| Nausea | ~32% | First 2–4 weeks at each dose increase | Smaller, more frequent meals. Avoid high-fat food. Eat slowly and stop when satisfied. Antiemetics (metoclopramide, ondansetron) can be prescribed at your free monthly Slinic check-in if needed. |
| Diarrhoea | ~23% | First 2–4 weeks at each dose | Temporarily reduce high-fibre foods. Increase fluid intake. Loperamide can help acutely. Review with Slinic if persistent beyond the first 4 weeks at a given dose. |
| Constipation | ~17% | Variable — can develop at any stage | Increase dietary fibre and fluid. Macrogol sachets (Movicol, Laxido) available without prescription from any Edinburgh pharmacy. Mention at monthly check-in if ongoing. |
| Vomiting | ~11% | First 2–4 weeks at each dose | Contact Slinic urgently if unable to keep any fluids down for more than 24 hours — dehydration risk is serious. |
| Fatigue / low energy | Common early | First few weeks | Usually reflects reduced calorie intake rather than direct drug effect. Ensure adequate protein intake (1.2–1.6g/kg ideal body weight daily). |
| Hair thinning (telogen effluvium) | Common with rapid weight loss | Months 3–6 | Increase protein intake. Check ferritin levels with your Edinburgh GP. Resolves naturally without stopping medication. |
| Injection site reactions | ~7% | Ongoing | Rotate injection sites: abdomen, thigh, upper arm. Clean technique. Usually mild redness or itching that resolves without intervention. |
Edinburgh Royal Infirmary — 51 Little France Crescent, EH16 4SA (main Edinburgh A&E) · Western General Hospital — Crewe Road South, EH4 2XU (North Edinburgh) · St John’s Hospital, Livingston — Howden Road West, EH54 6PP (West Lothian)
Severe persistent abdominal pain especially radiating to the back — stop medication immediately, attend Edinburgh Royal Infirmary A&E. Possible pancreatitis.
Facial swelling, throat tightening, or difficulty breathing — call 999 immediately. Possible anaphylaxis.
Unable to keep any fluids down for more than 24 hours — call Slinic, call NHS 24 (111), or attend urgent care.
Call NHS 24 on 111 for urgent non-emergency advice outside GP hours.
Who Prescribes Weight Loss Injections in Edinburgh — What to Verify
| What to check | Why it matters | Slinic status |
|---|---|---|
| GPhC registration — verify at pharmacyregulation.org | Legal requirement to dispense Mounjaro and Wegovy. The only way to verify a UK online pharmacy is legitimate. MHRA seized 20M counterfeit doses worth £45M in 2025. | ✓ GPhC No. 1033729 |
| NHS contract | Highest UK pharmacy governance standard — same audit standards as NHS pharmacies. No private weight loss competitor holds this alongside Slinic’s other credentials. | ✓ Yes — NHS-contracted |
| SCOPE Obesity accreditation | Specialist obesity clinical competency beyond general prescribing authority. | ✓ Yes |
| LegitScript certification | International online pharmacy verification used by Google and international regulators. | ✓ Yes |
| Named registered prescriber | Every prescription must be reviewed by a GMC, GPhC, or NMC registered prescriber. Not automated. | ✓ Shadeia Younis MPharmS GPhC No. 2052119 |
| Authorised UK supply chain | Must be MHRA-licensed medication from Eli Lilly / Novo Nordisk’s UK-authorised supply — not compounded, not overseas, not counterfeit. | ✓ Eli Lilly + Novo Nordisk UK-authorised supply only |
How to Get Started at Slinic — Edinburgh Patients
- Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation — free, no obligation, no GP referral needed. Takes 2 minutes.
- Registered prescriber review same working day — Shadeia Younis or her registered clinical team review your assessment personally. Contraindication screening, drug interaction review, ethnic threshold assessment. Never automated.
- Medication dispatched within 24 hours of approval — certified cold-chain packaging (2–8°C throughout transit) to your Edinburgh EH address. EH1–EH55 all covered. Next-day tracked delivery.
- Free monthly check-in scheduled — weight progress, dose management, side effects, nutrition guidance. All remote — no travel to a clinic. All included in your medication price.
- Ask your Edinburgh GP simultaneously for an NHS Lothian tier 3 referral. Also ask about the Scottish cardiovascular Wegovy pathway (BMI 27+ with established CVD, no T2D) and the Scottish T2D Mounjaro pathway (T2D patients). Start both routes today.
Frequently Asked Questions — Weight Loss Injections Edinburgh
Are NHS weight loss injections free in Edinburgh?
Yes — there is no NHS prescription charge in Scotland for any medication. Mounjaro or Wegovy prescribed through NHS Lothian costs you nothing. This is the fundamental advantage of Scottish NHS access compared to England, where the £9.90 per item charge applies. The barrier for Edinburgh patients is the 12–24 month tier 3 waiting time, not cost. Private Slinic prescriptions are not NHS prescriptions and carry the standard private prices listed on this page.
Where can I get weight loss injections in Edinburgh?
Two legitimate routes. NHS: ask your Edinburgh GP for an NHS Lothian tier 3 weight management referral (BMI 35+ with qualifying conditions, 12–24 month wait), or ask about the Scottish cardiovascular Wegovy pathway or T2D Mounjaro pathway if you have CVD or T2D. Private: complete Slinic’s free 2-minute assessment at slinic.co.uk — medication delivered next-day to your Edinburgh EH postcode. No GP referral needed for private route. Both routes run simultaneously without affecting each other.
How long is the NHS waiting list for weight loss injections in Edinburgh?
NHS Lothian tier 3 weight management waiting times are approximately 12–24 months from GP referral. The Scottish cardiovascular Wegovy pathway and Scottish T2D Mounjaro pathway may be significantly faster for eligible patients — ask your Edinburgh GP. Slinic has no waiting list: assessment to delivery within 24–48 hours to all Edinburgh EH postcodes.
Can Slinic prescribe weight loss injections to Edinburgh patients?
Yes. Slinic is GPhC-registered (No. 1033729 — verify at pharmacyregulation.org) and authorised to prescribe and dispense to patients across all four UK nations including Scotland. A private prescription from Slinic is fully legally valid in Scotland. Medication is dispensed from our Lancashire pharmacy and delivered cold-chain next-day to your Edinburgh EH address.
Does Slinic deliver to Edinburgh and the Lothians?
Yes. Slinic delivers next-day cold-chain to all Edinburgh and Lothians postcodes: EH1–EH55, covering Edinburgh City (EH1–EH17), East Lothian (EH21, EH31–EH42), Midlothian (EH18–EH27), and West Lothian (EH47–EH55). All deliveries maintain 2–8°C throughout transit from our Lancashire pharmacy to your door. Delivery requires a signature or pre-authorised safe place to ensure medication is not left in heat.
Can I get weight loss injections in Edinburgh and be on the NHS Lothian waiting list at the same time?
Yes — this is the bridge strategy that many Edinburgh patients now use. Ask your Edinburgh GP for an NHS Lothian tier 3 referral today (starting that 12–24 month clock immediately), and complete Slinic’s private assessment simultaneously. Starting private treatment at Slinic does not affect your NHS Lothian waiting list position. When your NHS Lothian appointment arrives in 12–24 months, you transition to completely free NHS supply at your current established dose — no restart from the beginning, and free indefinitely thereafter.
What is the Scottish Medicines Consortium (SMC) and how does it affect Edinburgh patients?
The Scottish Medicines Consortium (SMC) is Scotland’s equivalent of England’s NICE — it approves medicines for use in NHS Scotland. SMC has separately approved both Mounjaro and Wegovy for obesity management in Scotland. Because Scotland uses SMC rather than NICE, the April 2026 NICE cardiovascular Wegovy guidance and QOF T2D Mounjaro framework apply specifically to England. Scotland has equivalent pathways through the Scottish GMS contract — but the timing and specific criteria may differ. Always ask your Edinburgh GP about the current Scottish position, and ask them specifically about what SMC-approved pathways are available to you.
Is Mounjaro or Wegovy better for Edinburgh patients?
In the SURMOUNT-5 head-to-head trial (NEJM 2025), Mounjaro produced 20.2% average weight loss versus Wegovy’s 13.7% over the same period. For most Edinburgh patients prioritising maximum weight loss, Mounjaro is the stronger choice. However, Wegovy may be more appropriate if: you have established cardiovascular disease (Wegovy has the NICE cardiovascular benefit label based on the SELECT trial); you prefer a lower starting price (£99.99 vs £139); or you want an oral option (Wegovy pill MHRA-approved June 2026). Your Slinic prescriber will recommend the most appropriate medication at your assessment based on your individual clinical profile.
External Resources and References
Official NHS and Regulatory Resources
- NICE TA1026 — Tirzepatide (Mounjaro) for managing overweight and obesity (June 2025)
- NICE TA875 — Semaglutide (Wegovy) for managing overweight and obesity (March 2023)
- Scottish Medicines Consortium (SMC) — Mounjaro and Wegovy approvals in Scotland
- NHS Inform Scotland — Obesity information and support
- GPhC Register — Slinic verification (No. 1033729)
- MHRA — Report counterfeit medicines and enforcement actions
- SCOPE — Obesity clinical accreditation body
Published Clinical Trial Evidence
- SURMOUNT-1 — Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022
- STEP 1 — Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021
- SURMOUNT-5 — Garvey WT et al. Tirzepatide versus Semaglutide for Obesity. NEJM 2025
- SELECT — Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023
- SURPASS-2 — Frias JP et al. Tirzepatide versus Semaglutide in T2D. NEJM 2021
Patient Information and Support
Related Guides
Start Weight Loss Injections in Edinburgh Today
Same MHRA-licensed medication as NHS Lothian · Fixed 2026 prices · No waiting list · Next-day cold-chain delivery to all Edinburgh EH postcodes · GPhC No. 1033729
✓ NHS-contracted
✓ SCOPE Obesity Accredited
✓ LegitScript Certified
✓ Free monthly check-ins
✓ Free starter pack
✓ No subscription
✓ No minimum term
